Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APLS Apellis Pharmaceuticals Inc.

盘前交易 11-05 05:21:32 EST

28.56

+0.58

+2.07%

最高30.13	最低27.47	成交量930.51万
今开27.58	昨收27.98	日振幅9.49%
总市值34.78亿	流通市值23.39亿	总股本1.22亿
成交额2.70亿	换手率11.36%	流通股本8,189万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"APLS","market":"US","secType":"STK","nameCN":"Apellis Pharmaceuticals Inc.","latestPrice":28.56,"timestamp":1730754000000,"preClose":27.98,"halted":0,"volume":9305073,"delay":0,"floatShares":81889475,"shares":121766328,"eps":-2.726485,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.58,"latestTime":"11-05 05:21:32 EST","open":27.58,"high":30.125,"low":27.47,"amount":269613652.71843,"amplitude":0.094889,"askPrice":30.1,"askSize":25,"bidPrice":29.05,"bidSize":99,"shortable":3,"etf":0,"ttmEps":-2.726485,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730817000000},"adr":0,"listingDate":1510203600000,"adjPreClose":28.56,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":29.3,"preClose":28.56,"latestTime":"19:59 EST","volume":3629458,"amount":103663943.3382,"timestamp":1730768373133},"volumeRatio":4.5073601976114075,"optionData":{"bulkOrders":[{"symbol":"APLS","call":false,"expireDate":1731646800000,"strike":"25.0","timestamp":1730753607068,"price":0.6000000238418579,"volume":7000,"amount":420000,"type":"+"}]},"impliedVol":0.8317,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/APLS","defaultTab":"news","newsList":[{"id":"2480878715","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.09%报29.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480878715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480878715?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:08","pubTimestamp":1730732886,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时08分，Apellis Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.09%。截至发稿，该股报29.41美元/股，成交量49.5104万股，换手率0.41%，振幅6.81%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230806971a42fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230806971a42fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLS","LU1093756168.USD","BK4585","BK4588","LU1093756325.SGD","BK4505"],"gpt_icon":0},{"id":"2477894190","title":"Apellis Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%报26.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477894190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477894190?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:57","pubTimestamp":1729533434,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时57分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.00%。截至发稿，该股报26.60美元/股，成交量61.113万股，换手率0.50%，振幅4.93%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022015714ab6bca28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022015714ab6bca28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4505","LU1093756168.USD","BK4588","APLS","BK4139","BK4585"],"gpt_icon":0},{"id":"2469492463","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469492463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469492463?lang=zh_cn&edition=full","pubTime":"2024-09-24 22:14","pubTimestamp":1727187284,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日22时14分，Apellis Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.17%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242214459719c678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242214459719c678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","BK4585","BK4505","APLS","LU1093756325.SGD","BK4588"],"gpt_icon":0},{"id":"2469165497","title":"美国研究综述-Cardinal Health、Factset、Paylocity Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2469165497","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469165497?lang=zh_cn&edition=full","pubTime":"2024-09-23 15:33","pubTimestamp":1727076787,"startTime":"0","endTime":"0","summary":"    路透9月23日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括卡地纳健康、Factset 和 Paylocity Holding。要闻              * Cardinal Health Inc   ：贝尔德将目标价从137美元上调至140美元             * Factset   ：杰富瑞将目标价从435美元上调至486美元             * Marinus Pharmaceuticals Inc   ：奥本海默将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Paylocity Holding Corp   ：TD Cowen将目标价从171美元上调至186美元             * United Rentals Inc   ：摩根大通将目标价从780美元上调至940美元 以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","IE00BFXG1179.USD","BK4566","APLS","TNET","LU1201861165.SGD","LU0211328371.USD","CRMT","LU0211331839.USD","LU1880398554.USD","LU2517655374.HKD","UTHR","LU0310799852.SGD","LU1861558580.USD","LU0130103400.USD","CAH","LU0724618433.USD","LU2517655028.SGD","FDS","BK4516","LU0310800965.SGD","MLKN","LU2517655291.USD","KVUE","LU0980610538.SGD","URI","LU1169590202.USD","LU0006061336.USD","GM","LU0211327993.USD","F","MRNS","LU1861559042.SGD","LU1201861249.SGD","PCTY","BK4112","RBLX","LU1093756325.SGD","LEN","LU0162691827.USD","LU0477156797.USD","PYCR","GEV","CRBP","LU0477156953.USD","BK4559","LU1917777945.USD","BK4099","LU2264538146.SGD","BK4567"],"gpt_icon":0},{"id":"2469679124","title":"BUZZ-欧盟专家组确认对眼疾药物持否定意见，Apellis业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2469679124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469679124?lang=zh_cn&edition=full","pubTime":"2024-09-21 01:01","pubTimestamp":1726851662,"startTime":"0","endTime":"0","summary":" (更新)    9月20日 - ** Apellis制药公司  股价下跌14.3%至31.46美元，创下自2023年8月以来的最低水平 。** Apellis称欧洲药品监管机构的人用医药产品委员会 已确认对其实验性药物培西他克普兰持否定意见** Pegcetacoplan是一种治疗地理性萎缩的试验性药物，地理性萎缩是一种渐进性和不可逆的眼部疾病，是由于病变的生长破坏了负责视力的视网膜细胞而引起的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU1093756168.USD","BK4588","CHMP","APLS","BK4087","BK4139","BK4585","BK4505"],"gpt_icon":0},{"id":"2469729673","title":"BUZZ--美国股票走势-纽蒙特公司、耐克公司、和谐金矿公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2469729673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469729673?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:09","pubTimestamp":1726848585,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月20日 - 周五，华尔街主要股指下滑，原因是投资者在前一交易日因美联储大幅降息引发的反弹后按兵不动。美东时间11:33，道琼斯工业平均指数  下跌0.15%，报41,962.62点。标普500指数  下跌0.56%，报5,681.91点；纳斯达克综合指数  下跌0.91%，报17,850.471点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DDM","BAC","LU2210150020.SGD","NKE","NEM","PEP",".IXIC","SGXZ51526630.SGD","BK4515","LU1861559042.SGD","LU0097036916.USD","LU0011850046.USD","LU1363072403.SGD","LU1244550221.USD","LU0310800965.SGD","LU1366192091.USD","LEN","BK4207","LU0149725797.USD","LU2095319765.USD","DJX","FDX","APTV","ERIE","UDOW","DOG","LU2265009873.SGD","VC","CHWY",".SPX","SDOW","BK4566","LU1236620834.HKD","DAN","LU0289961442.SGD","APLS","RPD","ARQ","LU1668664300.SGD","INTU","LU1023059493.AUD",".DJI","BK4570","DXD","LU1496350171.SGD","CEG","CRBP"],"gpt_icon":1},{"id":"2468539625","title":"BUZZ--美国股票走势-Constellation Energy、Gold Fields、NovaBay Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2468539625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468539625?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:30","pubTimestamp":1726839004,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月20日 - 华尔街主要股指周五开盘表现平淡，因为投资者在美联储超预期降息引发的前一交易日反弹后按兵不动。美东时间9:19，道指电子盘  下跌0.11%，报42,010点。标普500指数小型股  下跌0.26%，报5703点；纳斯达克100指数小型股  下跌0.30%，报19791.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0048573561.USD","BK4504","IE00B7SZLL34.SGD","BK4122","BK4588","CEG","IE00B19Z3581.USD","LU0612318385.USD","LU0300736492.USD","LU0456854461.SGD","LU0320765489.SGD","LU1623119135.USD","LU1712237335.SGD","LU1496350502.SGD","LU1941712348.USD","APTV","LU2129689514.USD","BK4017","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU1878469433.USD","BK4581","LU2129689605.HKD","NEM","BK4570","LU0742534661.SGD","BK4585","LU1894683264.USD","BK4139","BK4131","LU0149725797.USD","LU0306807586.USD","LU0498741890.SGD","LU2129689431.USD","APLS","LU0256863811.USD","BK4097","LU0390134368.USD","CSTA.U","LU1223082519.USD","LU1074936037.SGD","LU0306806265.USD","LU0417517546.SGD","LU2249611893.SGD","RPD","BK4505"],"gpt_icon":1},{"id":"2468471716","title":"BUZZ--美国股票走势-耐克、巴蒂尔石油公司、金矿工人","url":"https://stock-news.laohu8.com/highlight/detail?id=2468471716","media":"Reuters","labels":["Executive Changes","Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468471716?lang=zh_cn&edition=full","pubTime":"2024-09-20 20:23","pubTimestamp":1726835026,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月20日 - 美国股指期货周五走低，暂停了前一交易日的涨势，在美联储本周早些时候对货币政策采取关键立场后，华尔街主要股指有望实现周涨幅。标普500指数小型股  下跌0.15%，报5,709.25点；纳斯达克100指数小型股  下跌0.20%，报19,810点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes,Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","IE00BKVL7J92.USD","LU1162221912.USD","FDX","LU1718418525.SGD","LU2129689605.HKD","LU1496350502.SGD","LU0256863902.USD","LU0052756011.USD","APLS","BK4588","LU0055631609.USD","LU1303367103.USD","LU1023059493.AUD","LU1668664300.SGD","LU0300736492.USD","NEM","LU0742534661.SGD","LU0070302665.USD","LU0098860793.USD","BK4131","LU0149725797.USD","BK4570","LU0306806265.USD","BK4581","LU1363072403.SGD","SG9999001143.SGD","BK4207","BK4505","LU0128525689.USD","LU2098885051.SGD","RPD","LU0640476718.USD","LU0320765489.SGD","IE00BFXG1179.USD","BK4139","LU1496350171.SGD","LU0306807586.USD","BK4504","IE00B19Z3581.USD","LU0048573561.USD","LU0971096721.USD","LU1366192091.USD","LU0310800965.SGD","LU0786609619.USD","NKE","LU1074936037.SGD","BK4585","BK4017"],"gpt_icon":1},{"id":"2468344646","title":"BUZZ-欧盟专家组确认对眼疾药物持否定意见，Apellis 公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2468344646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468344646?lang=zh_cn&edition=full","pubTime":"2024-09-20 18:51","pubTimestamp":1726829515,"startTime":"0","endTime":"0","summary":"    9月20日 - ** Apellis制药公司  股价盘前下跌3.7%至35.36美元 ** Apellis称欧洲药品监管机构的人用医药产品委员会 已确认对其实验性药物培西他克普兰持否定意见** Pegcetacoplan是一种治疗地理性萎缩的试验性药物，地理性萎缩是一种渐进性和不可逆的眼病，是由于病变的生长破坏了负责视力的视网膜细胞而引起的。** APLS 于 6 月份寻求重新审查  CHMP 对该药上市申请的负面意见 ** 截至上次收盘，该股累计下跌约 39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHMP","LU1093756168.USD","LU1093756325.SGD","BK4139","BK4505","BK4588","BK4087","APLS","BK4585"],"gpt_icon":0},{"id":"2468035645","title":"Apellis Pharmaceuticals, Inc.盘中异动 急速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468035645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468035645?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:04","pubTimestamp":1726754680,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时04分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.25%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220441a1db3331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220441a1db3331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLS","LU1093756168.USD","BK4585","LU1093756325.SGD","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2459476344","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报37.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476344","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476344?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:33","pubTimestamp":1723732393,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时33分，Apellis Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报37.84美元/股，成交量19.9541万股，换手率0.16%，振幅3.97%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522331397198d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522331397198d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4585","LU1093756168.USD","APLS","BK4505","BK4588","BK4139"],"gpt_icon":0},{"id":"2459926585","title":"美国研究综述-阿波罗、黑石、好时","url":"https://stock-news.laohu8.com/highlight/detail?id=2459926585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459926585?lang=zh_cn&edition=full","pubTime":"2024-08-13 16:45","pubTimestamp":1723538737,"startTime":"0","endTime":"0","summary":"    路透8月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、黑石和好时。要闻   * 阿波罗  ：杰富瑞将目标价从 129 美元下调至 114 美元  * Blackstone   ：杰富瑞将目标价从 138 美元上调至 147 美元 * 好时  ：高盛给予卖出评级 * Palomar Holdings Inc   ：KBW将目标价从96美元上调至113美元 * 沃尔玛   ：CFRA将目标价上调3美元至75美元  以下是路透周二报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AJG","AMCX","ARDT","AKYA","CTKB","HLT","ALTG","LU0175139822.USD","ENV","ADVM","AIG","ROAD","CMBM","EYPT","BVS","APO","BK4535","AZEK","IE00BKVL7J92.USD","CMPX","BK4116","DNMR","GIS","BOLD","CEG","LU1244550221.USD","CWEN","LU1720051017.SGD","LU1917777945.USD","BK4554","ESPR","GETY","LU1366333091.USD","APLS","AMPX","DUK","ARES","BX","DE","HSY","THG","FTRE","DYN","BK4533","CNNE","CAG","COMM","AKAM","GH","LU2211817866.USD"],"gpt_icon":0},{"id":"2458515130","title":"Apellis Pharmaceuticals, Inc.2024财年第二财季实现净利润-37.66百万美元，同比增加69.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458515130","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458515130?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:17","pubTimestamp":1723220260,"startTime":"0","endTime":"0","summary":"8月10日，Apellis Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-37.66百万美元，同比增加69.13%；其中营业收入为2.00亿美元，同比增加110.59%，每股基本收益为-0.30美元。从资产负债表来看，Apellis Pharmaceuticals, Inc.总负债6.40亿美元，其中短期债务6.21百万美元，资产负债比为1.42，流动比率为5.09。机构评级：截至2024年8月10日，当前有17家机构对Apellis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为70.65美元，其中最低目标价为41.00美元，最高目标价为96.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810001743958c4a9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810001743958c4a9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLS"],"gpt_icon":0},{"id":"1197076708","title":"异动解读 | Apellis Pharmaceuticals股价大涨 新药获批前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1197076708","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197076708?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:07","pubTimestamp":1723190866,"startTime":"0","endTime":"0","summary":"Apellis Pharmaceuticals Inc.(APLS.us)股价今日盘中大涨9.11%,报36.65美元/股,引发市场关注。分析人士认为,这与该公司新药前景看好有关。\n\n据相关新闻报道,Apellis Pharmaceuticals是一家生物制药公司,专注于通过抑制补体系统来治疗疾病。该公司目前正在推进多个新药研发项目,其中一款新药近期获得监管机构批准,前景看好。\n\n分析师表示,新药获批将为Apellis Pharmaceuticals带来新的收入增长点,有望推动公司业绩持续向好。此外,公司在补体系统治疗领域的技术优势也获得市场认可,投资者对其长期发展前景充满信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLS"],"gpt_icon":0},{"id":"2458441813","title":"美国研究综述-Amphastar Pharmaceuticals、G1 Therapeutics、Upwork","url":"https://stock-news.laohu8.com/highlight/detail?id=2458441813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458441813?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:55","pubTimestamp":1723136129,"startTime":"0","endTime":"0","summary":"    路透8月8日 - 华尔街证券分析师周四调整了对 Amphastar Pharmaceuticals、G1 Therapeutics 和 Upwork 等几家美国上市公司的评级和目标价。要点  * Amphastar Pharmaceuticals Inc   ：Piper Sandler 将目标价从 71 美元下调至 66 美元 * Charles River Laboratories International Inc   ：贝雅下调目标价至中性 * G1 Therapeutics Inc   ：H.C. Wainwright将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGCO","LU2264538146.SGD","BARK","CE","BYND","AMPH","ACM","LU0566484027.USD","BLK","ALIT","AEVA","ALLO","BDSX","LU2430703178.SGD","TCPC","BK4109","APP","CELH","BOOT","ALB","AADI","ASIX","ATGE","AIZ","BCSF","BK4107","ACAD","LU1599440770.SGD","LU2430703251.USD","BLNK","APLS","ASLE","LU0823414478.USD","LENZ","BLBD","LU2430703095.HKD","ATEX","ALEX","ARKO","AKA","AZEK","ASH","BWMN","BXSL","CAR","IE00B19Z9P08.USD","ADUS","AZPN","ALLK","LU1244550577.SGD"],"gpt_icon":1},{"id":"2457319580","title":"Apellis Pharmaceuticals, Inc.盘中异动 早盘快速上涨9.11%报36.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457319580","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457319580?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:31","pubTimestamp":1723123865,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时31分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速上涨9.11%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408082131059f1aa2d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408082131059f1aa2d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","APLS","LU1093756325.SGD","LU1093756168.USD","BK4588","BK4139"],"gpt_icon":0},{"id":"2456831266","title":"HC Wainwright &amp; Co.：维持Apellis Pharmaceuticals(APLS.US)评级，由买入调整至买入评级, 目标价由92.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456831266","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456831266?lang=zh_cn&edition=full","pubTime":"2024-08-03 05:21","pubTimestamp":1722633689,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU1093756325.SGD","BK4588","BK4505","BK4139","APLS","LU1093756168.USD"],"gpt_icon":0},{"id":"2456343555","title":"Apellis 制药公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456343555","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456343555?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:54","pubTimestamp":1722520486,"startTime":"0","endTime":"0","summary":"   * Apellis Pharmaceuticals Inc   报告，截至6月底的季度调整后每股亏损28美分，高于去年同期的每股收益1.02美元。华尔街预期为每股-42美分至-9美分。* 营收同比增长 110.3%，达到 1.9969 亿美元；分析师预期为 1.9107 亿美元。* Apellis Pharmaceuticals Inc公布的本季度每股收益为亏损30美分。* 该公司一季度亏损 3766 万美元。* Apellis Pharmaceuticals Inc本季度股价上涨了3.2%，今年迄今为止亏损了33.8%。* 医药同行的平均一致建议也是 \"买入\"。华尔街对 Apellis Pharmaceuticals Inc 的 12 个月目标价中位数为 81.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLS","LU1093756168.USD","BK4585","LU1093756325.SGD","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2456438885","title":"Apellis Pharmaceuticals, Inc.盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456438885","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456438885?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:32","pubTimestamp":1722519136,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时32分，Apellis Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.27%。Apellis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Apellis Pharmaceuticals, Inc.公司简介：Apellis Pharmaceuticals Inc是一家处于商业化阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过抑制补体系统来治疗具有高度未满足需求的疾病，在补体级联反应中的中心蛋白C3水平上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213216941fd001&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213216941fd001&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","IMRX","BK4505","LU1093756168.USD","BK4539","BK4588","BK4563","APLS","BK4139","BK4585"],"gpt_icon":0},{"id":"2456163288","title":"杰富瑞投资银行：维持Apellis Pharmaceuticals(APLS.US)评级，由买入调整至买入评级, 目标价由80.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456163288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456163288?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:03","pubTimestamp":1722449039,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4505","LU1093756325.SGD","BK4139","LU1093756168.USD","BK4585","APLS","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apellis.com","stockEarnings":[{"period":"1week","weight":0.0446},{"period":"1month","weight":0.0382},{"period":"3month","weight":-0.1866},{"period":"6month","weight":-0.3248},{"period":"1year","weight":-0.3901},{"period":"ytd","weight":-0.5229}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apellis Pharmaceuticals, Inc.于2009年9月25日根据德拉华州法律成立。该公司是一家商业阶段的生物制药公司，专注于发现、开发和商业化新型治疗化合物，通过在补体级联中的中心蛋白C3水平上抑制补体系统（作为免疫系统的一个组成部分）来治疗具有高度未满足需求的疾病。2023年2月，美国食品药品监督管理局（FDA）批准了SYFOVRE，这是首个获批治疗继发于年龄相关性黄斑变性（GA）的地理萎缩的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.018331},{"month":2,"riseRate":0.714286,"avgChangeRate":0.056236},{"month":3,"riseRate":0.571429,"avgChangeRate":0.044074},{"month":4,"riseRate":0.714286,"avgChangeRate":0.062825},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.025158},{"month":6,"riseRate":0.714286,"avgChangeRate":0.080149},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.099521},{"month":8,"riseRate":0.857143,"avgChangeRate":0.144378},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.143331},{"month":10,"riseRate":0.428571,"avgChangeRate":0.015269},{"month":11,"riseRate":0.714286,"avgChangeRate":0.119703},{"month":12,"riseRate":0.857143,"avgChangeRate":0.150428}],"exchange":"NASDAQ","name":"Apellis Pharmaceuticals Inc.","nameEN":"Apellis Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apellis Pharmaceuticals Inc.(APLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apellis Pharmaceuticals Inc.,APLS,Apellis Pharmaceuticals Inc.股票,Apellis Pharmaceuticals Inc.股票老虎,Apellis Pharmaceuticals Inc.股票老虎国际,Apellis Pharmaceuticals Inc.行情,Apellis Pharmaceuticals Inc.股票行情,Apellis Pharmaceuticals Inc.股价,Apellis Pharmaceuticals Inc.股市,Apellis Pharmaceuticals Inc.股票价格,Apellis Pharmaceuticals Inc.股票交易,Apellis Pharmaceuticals Inc.股票购买,Apellis Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apellis Pharmaceuticals Inc.(APLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apellis Pharmaceuticals Inc.(APLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}